More articles from Neuropharmacology

You have access
Persistent Spontaneous Oral Dyskinesias in Haloperidol-Withdrawn Rats Neonatally Lesioned with 6-Hydroxydopamine: Absence of an Association with the B _max for [³H]Raclopride Binding to Neostriatal Homogenates
Nuo-Yu Huang, Richard M. Kostrzewa, Chuanfu Li, Kenneth W. Perry and Ray W. Fuller

Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 268-276;
You have access
Inhibition of Lipopolysaccharide-Induced Nitric Oxide and Cytokine Production by Ultralow Concentrations of Dynorphins in Mixed Glia Cultures
Ling-Yuan Kong, Michael K. McMillian, Pearlie M. Hudson, Lei Jin and Jau-Shyong Hong

Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 61-66;
You have access
N-Methyl-d-aspartate Antagonist Activity of α- and β-Sulfallorphans
Vijay K. Shukla and Simon Lemaire

Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 357-365;
You have access
Psychopharmacological Profile of Amisulpride: An Antipsychotic Drug with Presynaptic D₂/D₃ Dopamine Receptor Antagonist Activity and Limbic Selectivity
Gh. Perrault, R. Depoortere, E. Morel, D. J. Sanger and B. Scatton

Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 73-82;
You have access
Pharmacological Characterization of SIB-1765F: A Novel Cholinergic Ion Channel Agonist
Aida I. Sacaan, Richard T. Reid, Emily M. Santori, Pamala Adams, Lucia D. Correa, Lorrence S. Mahaffy, Leo Bleicher, Nicholas D. P. Cosford, Kenneth A. Stauderman, Ian A. McDonald, Tadimeti S. Rao and G. Kenneth Lloyd

Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 373-383;
You have access
Neurochemical Characteristics of Amisulpride, an Atypical Dopamine D₂/D₃ Receptor Antagonist with Both Presynaptic and Limbic Selectivity
H. Schoemaker, Y. Claustre, D. Fage, L. Rouquier, K. Chergui, O. Curet, A. Oblin, F. Gonon, C. Carter, J. Benavides and B. Scatton

Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 83-97;
You have access
Effects of a Novel Cholinergic Ion Channel Agonist SIB-1765F on Locomotor Activity in Rats
Frédérique Menzaghi, Kevin T. Whelan, Victoria B. Risbrough, Tadimeti S. Rao and G. Kenneth Lloyd

Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 384-392;
You have access
Interactions between a Novel Cholinergic Ion Channel Agonist, SIB-1765F and L-DOPA in the Reserpine Model of Parkinson’s Disease in Rats
Frédérique Menzaghi, Kevin T. Whelan, Victoria B. Risbrough, Tadimeti S. Rao and G. Kenneth Lloyd

Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 393-401;
You have access
Blood-Brain Barrier Permeability and Bioavailability of a Highly Potent and μ-Selective Opioid Receptor Antagonist, CTAP: Comparison with Morphine
Thomas J. Abbruscato, Sarah A. Thomas, Victor J. Hruby and Thomas P. Davis

Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 402-409;
You have access
Decreases in Evoked Overflow of Dopamine in Rat Striatum after Neurotoxic Doses of Methamphetamine
Wayne A. Cass

Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 105-113;

Main menu

User menu

Search

More articles from Neuropharmacology

Pages

Navigate

More Information

ASPET's Other Journals